Inbiome
PrivateLast Round
Series A
Apr 1, 2026
Total Funding Raised
$16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inbiome is a biotechnology company that has developed a patented Molecular Culture technology, which uses machine learning and chemistry for rapid bacterial diagnostics and microbiome analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inbiome Comparables
Compare Inbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OCEAN Dx | 78% | |
| Pattern Bioscience | 77% | |
| bioMérieux | 69% |
Inbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2026 | ||||
| Grant | Jan 11, 2023 |
Inbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Slingshot Ventures | Series A |
| NATO Innovation Fund | Series A |
| Voima Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$16M round completed.
- Jan 22, 2026
Monthly visitors grew 789% MoM, reaching 7.5K.
Inbiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inbiome's valuation, stock price, and market status.
Is Inbiome a public or private company?
Inbiome is a private company.
What is the current stock price of Inbiome?
Inbiome is a private company with no public stock price. No recent secondary market data is available.
How much is Inbiome worth (valuation)?
Valuation information for Inbiome is not publicly available.
Can I buy Inbiome stock?
Inbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inbiome's last funding round?
Inbiome's most recent funding round was Series A on April 1, 2026.
Who are the main investors in Inbiome?
Key investors in Inbiome include European Innovation Council, Slingshot Ventures, NATO Innovation Fund.
Will Inbiome IPO soon?
No public IPO plans have been announced for Inbiome.
How can I track Inbiome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inbiome's secondary market activity and sign up for updates.